Aktie • Biotechnologie

MIRATI THERAPEUTICS

WKN
A1W1XV
ISIN
US60468T1051
Ticker
MRTX
• 26M
WKN
A1W1XV
Ticker
MRTX
• 26M
ISIN
US60468T1051
Marktkapitalisierung
–
Dividendenrendite
–
KGV
–
Gewinn pro Aktie
–
theScreener Rating
–
Nachhaltigkeits-Score
–

Unternehmens­daten

Stammdaten zu MIRATI THERAPEUTICS

WKN
A1W1XV
ISIN
US60468T1051
Home-Symbol
MRTX
Symbol
26M
Branche
Biotechnologie
Sektor
Chemie / Pharma / Gesundheit
Unternehmen
Unbekannt
Land

Marktdaten

Marktkapitalisierung
–
Anzahl Aktien
–
Streubesitz
–

Anteilseigner

EcoR1 Capital, LLCRTW Investments LPAvoro Capital Advisor LLCThe Vanguard Group, Inc.Wellington Management Co. LLPBoxer Capital LLCTavistock Life Sciences Co. (Investment Management)SSgA Funds Management, Inc.T. Rowe Price Associates, Inc. (Investment Management)Morgan Stanley & Co. LLCBlackRock Fund AdvisorsInvus Public Equities Advisors LLCOrbiMed Advisors Private EquityParadigm BioCapital Advisors LPCamber Capital Management LPBaker Bros. Advisors LPArmistice Capital LLCAdage Capital Management LPRock Springs Capital Management LPCitadel Advisors LLC
  • EcoR1 Capital, LLC (10,54 %)
  • RTW Investments LP (9,65 %)
  • Avoro Capital Advisor LLC (9,50 %)
  • The Vanguard Group, Inc. (8,02 %)
  • Wellington Management Co. LLP (4,73 %)
  • Boxer Capital LLC (4,56 %)
  • Tavistock Life Sciences Co. (Investment Management) (4,47 %)
  • SSgA Funds Management, Inc. (3,91 %)
  • T. Rowe Price Associates, Inc. (Investment Management) (3,41 %)
  • Morgan Stanley & Co. LLC (3,39 %)

Kontakt